Lv1
88 积分 2024-11-03 加入
Structural Optimization of Next-Generation TRK Inhibitors against Acquired Drug Resistance Mutations for the Treatment of Solid Tumors
7天前
已完结
Skin Cancer after Ruxolitinib or Belumosudil
2个月前
已完结
Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRASG12D
7个月前
已完结
Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRASG12D
8个月前
已完结
皖公网安备34019202002308
